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Rostrum

Factors affecting the determination of
threshold doses for allergenic foods:
How much is too much?
Steve L.Taylor, PhD,a Susan L. Hefle, PhD,a Carsten Bindslev-Jensen, MD,b
S. Allan Bock, MD,C A. Wesley Burks, Jr, MD,d Lynn Christie, RD,d David J. Hill, MD,e
Arne Host, MD.f Jonathan O'B. Hourihane, MD,g Gideon Lack, MDnh
Dean D. Metcalfe, MD,i Denise Anne Moneret-Vautrin, MD,I Peter A. Vadas, MD,k
Fabienne Rance. MD.1 Daniel J. Skrypec, PhD,mThomas A.Trautman, PhD,"
Ingrid MalmhedenYman, PhD.0 and Robert S. Zeiger, MDp Lincoln, Neb, Odense, Den-

mark, Boulde~Colo, Little Rock, Ark, North Melbourne, Australia, Southampton and London,
United Kingdom, Bethesda, Md, Nancy and Toulouse, France, Toronto, Ontario, Canada, Glenview, Ill, Minneapolis, Minn, Uppsala, Sweden, and San Diego, Calif

Background: Ingestion of small amounts of an offending food
can elicit adverse reactions in individuals with IgE-mediated
food allergies. The threshold dose for provocation of such reactions is often considered to be zero. However, because of various practical limitations in food production and processing,
foods may occasionally contain trace residues of the offending
food. Are these very low, residual quantities hazardous to
allergic consumers? How much of the offending food is too
much? Very little quantitative information exists to allow any
risk assessments to be conducted by the food industry.
Objective: We sought to determine whether the quality and
quantity of existing clinical data on threshold doses for commonly allergenic foods were sufficient to allow consensus to be
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reached on establishment of threshold doses for specific foods.
Methods: In September 1999,12 clinical allergists and other
interested parties were invited to participate in a roundtable
conference to share existing data on threshold doses and to
discuss clinical approaches that would allow the acquisition of
that information.
Results: Considerable data were identified in clinical files
relating to the threshold doses for peanut, cows' milk, and egg;
limited data were available for other foods, such as fish and
mustard.
Conclusions: Because these data were often obtained by means
of different protocols, the estimation of a threshold dose was
very difficult. Development of a standardized protocol for clinical experiments to allow determination of the threshold dose
is needed. (J Allergy Clin Immunol2002;109:24-30.)
Key words: Allergy, food, chullmge, threshold dose

How much is too much? Allergists laow that exposure
to small quantities of the offending food can elicit
adverse reactions, sometimes even severe reactions, in
~ . ~ all
individuals with IgE-mediated food a l l e r g i e ~ . For
practical purposes, allergists have always assumed that
the threshold dose for the offending food was zero. When
advising patients to adhere to specific avoidance diets,
such advice is probably prudent.

FOOD INDUSTRY PREDICAMENT
A zero tolerance for the offending food creates enormous practical problems for the food industry. From a
practical economic perspective, the food industry must
manufacture many different food products within the
same manufacturing facility. In some facilities several
hundred different products are manufactured within a single building. In such situations trace residues of a specific food could come into contact with another food being
manufactured in the same facility.L4 Furthermore, the
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food industry often uses shared equipment to manufacture
related food products. A few examples include ice cream
and sorbet, cookies or other baked goods with varying
formulations, egg-free and egg-containing pastas, and
chocolate confections with differing ingredients. When
one product containing a food allergen is manufactured
on shared equipment just before another product that does
not contain the same food allergen, the equipment must
be scrupulously cleaned between manufacturing of the 2
products. This is necessary to avoid the possibility that
potentially hazardous residues of an allergenic food will
enter a product that is not supposed to contain that ingredient. But how clean is clean enough?
The chains of distribution of foods and their ingredients can be quite complex in today's worldwide food
industry. Opportunities exist for food products to come
into contact with allergenic foods or ingredients throughout this complex supply chain. As an example, soybeans
and corn are often harvested on the same Midwestern US
farms at the same time of the year. Harvesting equipment, transportation vehicles, and storage facilities are
often shared. Corn, which is not typically an allergenic
food, can become contaminated with residual soybeans,
a more common allergenic food. This contamination can
be carried through to processed corn products. Are low
levels of residual soybeans in corn products potentially
harmful to consumers with soybean allergy?
These situations illustrate the plight faced by the food
industry in their efforts to protect the well-being of allergic consumers. The farm-to-table food production, processing, and distribution chain needs better information on
the threshold dose for provocation of allergic reactions to
foods. The proliferation of precautionary labels (eg, "may
contain peanuts") is an industry response to the existing
uncertainty. Without information on threshold doses, it is
difficult for the food industry to conduct risk assessments
and to focus their quality-control efforts where the benefit
to the allergic consumer would be the greatest.

CLINICAL CONSIDERATIONS
The medical community would also benefit from
increased information regarding threshold doses. These
same situations described above create questions for allergists and their patients with food allergy that cannot be adequately answered without some knowledge of the threshold
dose below which reactions are unlikely to occur.
Evidence is needed on the threshold dose for the
offending food among sensitive individuals and the level
of the offending food present in the food product under
consideration to conduct an assessment of the risk posed
by trace residues of allergenic foods in other food prod-
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ucts. The threshold dose might best be defined as the
lowest amount of the offending food that would elicit
mild, objective symptoms (eg, mild urticaria, erythema,
and oral angioedema) in the most sensitive individuals.
The amount of the offending food needed to elicit symptoms is variable, possibly over an order of magnitude or
more between different individuals with the same type of
food allergy.5 Many factors contribute to this variability.
Intraindividual variability probably also occurs as a
result of potentiating factors, such as exercise, alcohol,
and acetylsalicylic acid.6 Also, the threshold doses for
different allergenic foods (eg, peanuts and eggs) are not
necessarily equal.

EPISODES ASSOCIATED WITH UNDECLARED
ALLERGENS IN FOODS
Presently, very little information exists on the basis of
which to estimate the threshold dose for specific allergenic
foods. Anecdotal reports indicate that reactions have
occurred from such incidental contacts as opening packages of the offending food, wiping counters or tables having peanut residues, inhaling vapors from cooking of the
food, use of shared utensils, and kissing the lips of someone who has eaten the offending food.7 Although such
anecdotal reports confirm that ingestion of very small
amounts of allergenic foods may provoke allergic reactions in some sensitive individuals, they do not provide
quantitative information on the lowest provol<ingdose.
More quantitative estimates of the lowest provol<ing
dose can be derived from actual allergic reactions occurring in patients from whom careful histories are taken
regarding the amount of the offending food that was
ingested. In the case of foods contaminated with trace
residues of an allergenic food, such histories must be
coupled with a quantitative analysis of the amount of the
allergenic food found in the implicated product. Comparatively few such estimates have been made involving
a rather small number of individuals. This is probably
because of the lack of simple methods for the analysis of
the implicated food product for residues of commonly
allergenic foods. In the investigation of a case involving
frozen Tofutti containing undeclared mill< residues, the
ingestion of an amount of tofutti equivalent to 2.5 mL of
. ~ the investigation of a case
milk elicited a r e a ~ t i o n In
involving hot dogs containing undeclared mill< residues,
the ingestion of an amount of the hot dogs equivalent to
0.3 mL of milk elicited reactions in several children.2 In
a case involving the ingestion of sorbet manufactured on
shared equipment with ice cream, a child with milk allergy reacted after eating an unknown amount of sorbet
containing 0.52% (wtlwt) milk protein.4 In a similar
episode a child with mill<allergy apparently reacted after
eating approximately 4 to 6 oz of sorbet containing less
than 200 pg of whey protein.' Malmheden Yman et a18
reported a series of incidents related to inadvertent or
unexpected exposure to allergenic foods that resulted in
allergic reactions among sensitive individuals. Many of
these incidents involved exposure to small quantities of
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the offending food, including milk in 9 incidents at levels ranging from 0.04% to 1.1% (wtlwt), egg in 3 incidents at levels ranging from 0.003% to 0.16% (wt/wt),
wheat gluten in 2 incidents at levels ranging from 0.3%
to 1.3% (wtlwt), soy protein in 2 incidents at levels ranging from 0.5% to 7.0% (wt/wt), and hazelnut in 1 incident at a level of 0.2% (wt/wt). Quantitative exposure
information was available in several of these cases. Fatal
anaphylaxis occurred in a consumer with milk allergy
after eating approximately 100 g of a sausage product
containing 0.06% undeclared casein that equated to 60
mg of casein.8 An asthmatic reaction occurred in an individual with hazelnut allergy after ingestion of about 3 to
6 g of a chocolate confection containing 0.2% of undeclared hazelnut that equated to 6 to 12 mg of hazelnut.8
Although such episodes reveal the hazards posed by
undeclared residues of allergenic foods contaminating
other foods, they are not particularly suitable for establishing the lowest provoking dose. For example, the circumstances of exposure, including the amount and type
of foods eaten during the episode, can only be determined anecdotally. Also, the reliability of the analytic
results can be questioned because validated, collaboratively studied, standard methods are not yet available.

CLINICAL APPROACHESTOTHRESHOLD
DOSE ESTIMATION
The best estimates of the threshold dose for various
allergenic foods can be obtained from controlled clinical
challenge trials. In only a few cases were such trials intended specifically to determine the threshold dose.5.9 More frequently, challenges have been conducted for diagnostic
purposes rather than for determining the lowest provoking
dose. However, typical protocols involve starting at doses
that are one half or less of the amount of the offending food
estimated by the patient to provoke syrnptoms.'o
Because low doses of allergenic foods are sometimes
used in the diagnosis of food allergies, especially in
patients with histories of serious allergic reactions, the
possibility exists that data on the threshold doses for
common allergenic foods might exist in certain allergy
clinics. Consequently, in September 1999, the Food
Allergy Research and Resource Program at the University of Nebraska, with sponsorship from the food industry,
convened a roundtable conference entitled "Threshold
Doses for Allergenic Foods: How Much Is Too Much?"

RESULTS OFTHE ROUNDTABLE
Several clinical groups did possess potentially useful
information relating to the threshold doses for commonly
allergenic foods derived from the results of past doubleblind, placebo-controlled, food challenges (DBPCFCs)
used for diagnostic purposes. The most useful data were
available on peanuts, eggs, and cows' milk and will be
reported here. Some data were also available on fish and
mustard seed. Data were also available for soybeans,
wheat, sesame seed, tree nuts, and crustaceans, but the

number of vatients tested was too few, and in some cases,
the nature of the challenge materials was not precisely
known (eg, the variety of tree nuts, the form of soybean,
and the method of processing or species of crustacean).
Table I contains the results of the accumulated data on
the lowest provoking doses in DBPCFCs for the various
investigators involved in the roundtable conference for
peanuts, eggs, and cows' milk. For peanut, results were
shared on DBPCFCs (and some single-blind, placebocontrolled food challenges [SBPCFCs] and open challenges) of 306 patients. The lowest provoking dose was 1
mg of peanut, which was seen with 4 patients; all of these
patients were from the clinic of Dr Fabienne Rance in
France. The range of lowest provoking doses for these
patients was 1 mg to 5 g. For eggs, results were shared on
DBPCFCs (and some SBPCFCs and open challenges) of
281 patients. The lowest provoking dose was 1 mg of liquid whole egg, which was seen with 2 patients, both from
the clinic of Dr Rance in France. The range of lowest
provoking doses for these patients was 1 mg to 5 g. For
cows' milk, the results are much more difficult to interpret because several different forms of cows' milk were
used in the challenges: liquid cows' milk, nonfat dry
milk, and infant formula. For cows' milk, results were
shared on DBPCFCs (and a few SBPCFCs and open
challenges) of 299 patients. The lowest provoking dose
was 0.02 mL of milk, which was seen in 21 patients; all
of these patients were from the clinic of Dr David Hill
from Australia. The range of lowest provoking doses for
these patients was 0.02 m~ to greater than 100 mL. For
fish, the lowest provoking dose was 5 mg of either cod or
herring, as determined from the results of DBPCFCs
(and some SBPCFCs) on 32 patients. However, the
species of fish used in these challenges were variable,
and this appeared to affect the results, as noted from
comparative information obtained on 14 patients for 4
different species by Dr Carsten Bindslev-Jensen in Denmark. Fifteen individuals with mustard allergy have been
evaluated by means of DBPCFCs in France, and the most
sensitive individual reacted to 1 mg of ground mustard
seed. To apply this information in the context of a typical
serving of food containing undeclared residues of an
allergenic food, 1 mg of an allergenic food in a typical
50-g serving would be equivalent to 20 mg of allergenic
food per kilogram of the ingested food product (20 ppm).

DISCUSSION
Clearly, sufficient results are available to conclude that
the threshold doses for commonly allergenic foods are
finite, measurable, and above zero. However, attempting
to reach consensus on the threshold doses for peanut,
egg, cows' milk, fish, and mustard on the basis of the
existing data would probably be premature for a number
of reasons. The number of patients who have been subjected to DBPCFCs with low doses of the offending food
is probably sufficient to estimate the threshold dose at
least for peanut, egg, and cows' milk. However, the
nature of the data suggests that it may be premature to
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TABLE I. Lowest provoking dose for commonly allergenic foods
Physician
or group

Peanut

Egg

No. of
patients

Nature of
challenges
(DB or SB)

14
3
5
69
10
6
100
74
28
9
19
8
91

DB
DB
DB
DB
DB
SB
Open
DB
DB or SB
DB or SB
DB
DB or SB
DB

Hill
Rance

100
38

Open
DB

Lack
Lack
Bindslev-Jensen and ~ o r ~ a a r d l l
Hill
Bock
Burks and Christie
Rance
Lack
Moneret-Vautrin #1
Zeiger
Host

13
5
3
100
66
21
31
6
6
56
15.Ahh
15.1**
6
4
14
14

SB
SB
DB
Open
DB
DB
DB
SB
DB or SB
DB
DB
DB
DB
DB or SB
DB
DB

Hourihane
National Jewish
Bindslev-Jensen and Mortzi
Bock
Burks and Christie
Lack
Hill
Rance
Moneret-Vautrin #1
Moneret-Vautrin #2
Moneret-Vautrin #1
Moneret-Vautrin #2
Bock

Lowest provoking dose
Amount of food

Amount of protein

4.3 mg
10 mg
160 mg
50 mg
400 mg
500 mg
1 drop of PB
I mg
5 mg (SB), 10 mg (DB)
265 mg
2 mg
265 mg
20 mg

2 mg
2.5 mg
40 mg
1.25 mg
I00 mg
125 mg
6 mg
0.25 mg
1.25 mg, 2.5 mg
66 mg
0.2 mg
26.5 mg

100 mg
200 mg
5000 mg
0.02 mL
2 mL
400 mg
0.5 mL
5 mL
I mL (DB), 5 mL (SB)
0.1 mL
5 mL
5 mL
16 mg
15 mg (SB), 65 mg (DB)
5 mg
500 mg

10 mg
20 mg
180 mg
0.6 mg
67 mg
140 mg
15 mg
150 mg
30 mg, 150 mg
1.5 mg
75 mg
75 mg
Unknown??
Unknown
Unknown
Unknown

Bindslev-Jensen and Norgaard
Burks and Christie

Milk

Fish

Mustard

Rance
Moneret-Vautrin #1
Bindslev-Jensen and Hansenii
Bindslev-Jensen and Hansenii
Bindslev-Jensen and Hansenii
Bindslev-Jensen and Hansenii
Bock
Rance

Unknown
Unknown
Unknown
0.3 mg

Form

PF?
Ground peanut
Ground peanut
Ground peanut
PB
Ground peanut
PB
Ground peanut
Ground peanut
Ground peanut
EW§
EW§
Dried EW or
whole egg
Whole eggq
(raw)
Dried whole
egg
EW (raw)
Whole egg
(raw)
EW (cook)
EW (raw)
Milk
Milk
NFDM
NFDM
Milk
Milk
Milk
Formula#
Formula#
Formula#
Minced fish
Minced fish
Minced cod
Minced
mackerel
Minced herring
Minced plaice
Minced fish
Ground mustard
seed

DB, Double-blind; SB, s~ngle-blind;PF, Peanut tlour; PB, peanut butter; EW, egg wh~te;NFDM, nonfat dry mllk.
+Peanut tlour is assumed to contain 50% protein unless the value is specifically known.
?Work conducted also with Charlotte Mortz, PhD.
$Li uid egg white has an average protein content of 10%; dried egg whlte has an average protein content of 90%.
~ 0 conducted
%
also with Astrid Norgaard, PhD.
YlWhole egg has an average of 13% protein on a liquid basis and 50% protein on a dry basis.
#Cows' milk formula is estimated to conrain 15 g of milk protein per liter.
""Cows' milk allergy (A) or cows' milk intolerance (I).
++The protein content of the fish was not measured and may have been variable on the basis of the type of fish used
ZZWork conducted also with Tine Hansen, PhD.

attempt such an estimate. Because the experiments were
usually designed for diagnostic purposes rather than for
determination of the threshold dose, several experimental
design elements may contribute to the difficulty in reach-

ing consensus on the basis of the current data set. Certainly, a variety of different protocols were used in the
various clinics where the data were generated. Thus commingling of the data may not be entirely appropriate.
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TABLE II. Typical amounts o f protein i n challenge vehicles
Typical amount of protein contained*
mL

Food-challenge material

Whole m i k
Infant formula (milk protein)
NFDM
Egg white, liquid
Whole egg, liquid
Egg white, dried
Whole egg, dried
Peanut butter
Peanut flour, defatted

30-36 g
15 g

30-36 mg
15 mg

10 g
13 g

10 mg
13 mg

Fluid oz

FI

NFDM, Nonfat dly milk.
*Units of measure, such as drops or teaqpoonr (for dried or parte materials), can be dificult to quantify

The major reason for not estimating a threshold dose
on the basis of the available data is that the no-observedadverse-effect level (NOAEL) was not established for the
vast majority of the patients involved in these trials. In
risk assessments used by the World Health Organization,
the Food and Agriculture Organization of the United
Nations, and various worldwide regulatory agencies to
establish acceptable daily intakes (virtually safe doses)
for food additives, the NOAEL is first established on the
basis of research with experimental animals or observations on human subjects." Uncertainty factors are then
applied, on the basis of such factors as the need to extrapolate from experimental animals to human subjects, to
estimate the acceptable daily intake.12 Regulatory toxicologists often apply an uncertainty factor of 10 when
attempting to extrapolate data from experimental animals
to human subjects. Another factor of 10 is often applied
to account for possible human-to-human variability.
Thus the NOAEL generated from a toxicologic study in
rats or mice is typically divided by 100 to estimate a safe
dose for human subjects.l' In attempting to estimate a
threshold dose for allergic individuals from the available
clinical data, a key issue would be the magnitude of the
uncertainty factor to use in the risk assessment. A factor
of 10 would generally be considered appropriate in most
situations in which experimental data are available on
human subjects, but the suitability of this uncertainty factor for application to the determination of threshold
doses for allergenic foods requires extensive discussion.
In the data presented at this roundtable conference, the
lowest provoking dose for each individual patient was
known. For risk-assessment purposes, this dose would be
the lowest-observed-adverse-effect level (LOAEL).
Because the DBPCFCs were being performed for diagnostic purposes, only the LOAEL was recorded. For the
purposes of estimating a threshold dose, it would be
preferable to have information on the NOAEL. The highest dose in the DBPCFCs that did not elicit an adverse
reaction should be known to determine the NOAEL.
However, that information was not generally available
because the most sensitive patients involved in these challenge trials reacted to the first and lowest dose used. This
dose is thus the LOAEL, and uncertainty exists about how

much less of the offending food would be required to
reach the NOAEL. Although the LOAEL could be used to
estimate the threshold dose, that would introduce an additional uncertainty factor of indeterminate magnitude.
Because an uncertainty factor would need to be applied to
estimate the NOAEL from the LOAEL and because no
consensus has been reached on the size of that uncertainty factor, no attempt was made at this time to estimate a
NOAEL for peanut, egg, or milk.
Other factors also argue against establishment of a
threshold dose at this time. One question involves
whether the patients selected for DBPCFCs are representative of the entire population of individuals with allergies to that specific food. Most physicians acknowledge
excluding some of the most seriously affected patients
(ie, those with histories of anaphylactic shock) from
challenge trials. It could be argued that these patients
may be among the very most sensitive. Therefore if using
data on the basis of an incomplete set of the relevant
patients, some adjustments might need to be made with
uncertainty factors. In the data presented here, some
physicians excluded severely affected patients, whereas
others did not. In consideration of the existing data on
threshold doses for allergenic foods, the critical debate
might center around whether the usual 10-fold uncertainty factor would be suficient to account for the most sensitive individuals in the population, who may not have
been included in the clinical experiments. Would individuals exist who were more than 10 times as sensitive as
the most sensitive individual in the tested group?
The age and body weight of the patients may also be a
consideration. The lowest provoking doses expressed in
Table I are presented as milligrams of protein or food.
Some of the challenges were conducted on infants and
young children, whereas others were conducted on
adults. Should provoking doses be expressed on a weight
basis (eg, milligram per kilogram) of body weight?
The nature of the challenge material is another factor
creating some uncertainty. The standardization of challenge materials would certainly ease the comparative
interpretation of the results. For peanut, most clinicians
used ground peanuts as their challenge material and
expressed their results as milligrams of peanut. However,
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in one case Deanut butter was used. In another cases
peanut flour was used. In such cases assumptions must
be made in expressing the challenge doses in milligrams
of peanut or peanut protein. For eggs, most of the investigators used egg white as the challenge material,
although some used whole egg. One investigator used
both raw and cooked egg white. In Table I the results
were converted to milligrams of egg protein to obtain a
more consistent basis for comparison. With cows' milk,
the situation is even more confusing. Liquid milk, nonfat
dry milk, and infant formula are used as challenge materials. In Table I the data were converted to milligrams
- of
milk protein, but the conversion required some important
assumptions regarding appropriate conversion factors.
Table I1 provides a summary of the differing amounts of
protein found in various forms of cows' milk, egg, and
peanut. These differences highlight the interpretive problems associated with the use by various clinicians of different forms of the specific foods in the challenge. Standardization of this aspect would be helpful in obtaining
easily comparable data from different clinics.
The specific allergen content of the challenge materials may also affect the estimation of the threshold dose.
Peanut, cows' milk, and egg contain multiple allergens,14-16 and individual patients respond to different
allergens.17.18 If the content of the specific allergens
varies from one challenge
- material to another. that could
affect the likelihood that certain patients would react at
specific low doses and the estimation of the threshold
dose. For example, the proportion of the major egg allergens Gal d 1 and Gal d 2 as a function of total protein
would be higher in egg white than in whole egg. However, this consideration lilcely has little effect on the data for
cows' millc and peanut because the proportion of specific allergens as a function of total protein would not
change as a consequence of defatting or other processes.
Also, in the case of peanut, little difference appears to
occur in the specific allergen content as a function of
variety or agronomic conditions.lg
Other features of the challenge trials were also variable, which introduces additional uncertainty. As already
aclcnowledged, a few challenges, usually on the very
youngest patients, were done single-blind or open rather
than double-blind. Labial challenges are also occasionally used, although no such data are actually reported in
Table I. In addition to the nature of the challenge material, as noted above, the nature of the challenge vehicle
also varies, although this hopefully has limited effect on
the results. The time interval between administration of
the doses in a DBPCFC also varies. However, this factor
likely did not have much effect on the estimation of the
lowest provoking dose because the most sensitive
patients reacted to the first dose administered. Clearly,
the determination of the NOAEL and the estimation of
the threshold doses would be much easier if the
DBPCFCs were standardized with respect to all of the
important factors.
Once a NOAEL is obtained (and it is possible to estimate a NOAEL from a LOAEL by applying some uncer-

tainty factor), then the threshold dose could be estimated
by the application of additional uncertainty factors. The
primary source of remaining uncertainty would be with
regard to human-to-human variability. Although data
were obtained from DBPCFCs on more than 250 subjects
with peanut, egg, and cows' milk, the range of lowest provoking doses was widely variable from one individual to
the next. The range was several orders of magnitude for
all 3 foods. But the most sensitive individual may not
have been included in any of these trials. Therefore some
uncertainty factor would need to be applied to the available data. However, because the risk assessment process
was quite new to most of those attending this roundtable
conference, no consensus was reached on the magnitude
of the uncertainty factor that would be applied.
Some uncertainty will likely always remain regarding
whether the threshold dose has been determined for the
most sensitive individuals. Clinicians will never be completely certain that the most sensitive individual has been
identified and tested. However, an analogy can likely be
drawn to the infant formula industry, in which hypoallergenic infant formula based upon extensively hydrolyzed
casein is safe for the vast majority of infants with milk
allergy. Yet hypoallergenic infant formula is known to
elicit adverse reactions in a very small minority of such
infants. This analogy illustrates the difficulty in developing threshold doses, even with the application of uncertainty factors that will protect all allergic consumers.
Instead, the goal should be to identify threshold doses
that protect the vast majority of allergic consumers. Furthermore, the use of an uncertainty factor, as described
earlier, may correct these concerns.
In summary, the threshold doses for peanut, egg, and
cows' milk appear to be in the low milligram range or
higher for most individuals with allergies to those particular foods. Thus these individuals can (and probably do)
ingest foods, on occasion, containing lower amounts of
their offending food without any untoward reactions. We
recommend that international efforts be undertalcen to
establish threshold doses for commonly allergenic foods
using standardized clinical challenge protocols and using
as wide a range of affected patients as possible.
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